Abstract
Background Poorly managed medical waste produced at the health facilities are potential source of infections including occupational exposure to Hepatitis B Virus (HBV). This study evaluated the prevalence of HBV infection among healthcare workers (HCW) in Kisumu County.
Methods We determined the prevalence of HBV infections among 192 HCW from nine purposively selected high volume public hospitals in Kisumu County. A structured questionnaire was administered, and 4.0 ml of venous blood sample collected for Hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (anti-HBs) and total hepatitis B core antibody (anti-HBc) testing using enzyme immunoassay (EIA).
Results Of the 192 HCW sampled, 52.1% were males and 78.7% are married, the median participants age was 34.4 years with interquartile range (IQR) of 11 years. Most participants had between 1-5 years of service while 43.8% had ≥2 doses of HBV vaccine.
The respective prevalence of HBsAg, anti HBs and anti HBc was 18.8% (95% CI: 13.5-25.0%), 63.0% (95% CI: 55.8-69.9%) and 44.8% (95% CI: 37.6-52.1%). Higher proportion of HBV positive was found in HCW who had worked for less than one year and who had not received any dose of HBV vaccine at 37.5% and 35.9 % respectively.. Significant risk of HBV lifetime exposure was noted among HCW with one vaccine dose, those with no known exposure and highest in those with knowledge on HBV transmission (aOR, 7.97; 95% CI, 2.10-153.3, p-value=0.008). HCW who had received ≥2 doses of HBV vaccine (aOR, 0.03; 95% CI, 0.01-0.10, p-value= <0.0001) had significant HBV protection. Duration of service was not associated with HBV among HCW.
Conclusion Prevalence of HBV infection was high among HCW in Kisumu County. Ministry of health Kenya should strengthen comprehensive infection prevention and control practices to reduce lifetime exposure to HBV infection among HCW.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
None
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Jaramogi Oginga Odinga Teaching and Referral Hospital IERC Ref: IERC/JOOTRH/244/20 and National Commission for Science, Technology & Innovation (NACOSTI) granted research permit to conduct the study (license no: NACOSTI/P/20/6300). Participation in this study was voluntary and written informed consent was obtained from all the participants who accepted to be part of the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data collected have been reported in this manuscript
